Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1233 ARTÍCULOS , VIENDO DEL 1156 AL 1170

Cognitive Impairment, Alzheimer's Disease, and Other Dementias in the Lives of Lesbian, Gay, Bisexual and Transgender (LGBT) Older Adults and Their Caregivers: Needs and Competencies

Fredriksen-Goldsen KI, Jen S, Bryan AEB, Goldsen J.

J Appl Gerontol. 2018 May;37(5):545-569. doi: 10.1177/0733464816672047. Epub 2016 Oct 10.

The role of neuropathological markers in the interpretation of neuropsychiatric disorders: Focus on fetal and perinatal programming

Fanni D, Gerosa C, Rais M, Ravarino A, Van Eyken P, Fanos V, Faa G.

Neurosci Lett. 2018 Mar 16;669:75-82. doi: 10.1016/j.neulet.2016.10.063. Epub 2016 Nov 3.

Review of the advances in treatment for Alzheimer disease: Strategies for combating β-amyloid protein

Folch J, Ettcheto M, Petrov D, Abad S, Pedrós I, Marin M, Olloquequi J, Camins A.

Neurologia (Engl Ed). 2018 Jan-Feb;33(1):47-58. doi: 10.1016/j.nrl.2015.03.012. Epub 2015 May 11.

Vascular pathology: Cause or effect in Alzheimer disease?

Rius-Pérez S, Tormos AM, Pérez S, Taléns-Visconti R.

Neurologia (Engl Ed). 2018 Mar;33(2):112-120. doi: 10.1016/j.nrl.2015.07.010. Epub 2015 Sep 16.

The potential of virtual reality-based training to enhance the functional autonomy of Alzheimer's disease patients in cooking activities: A single case study

Foloppe DA, Richard P, Yamaguchi T, Etcharry-Bouyx F, Allain P.

Neuropsychol Rehabil. 2018 Jul;28(5):709-733. doi: 10.1080/09602011.2015.1094394. Epub 2015 Oct 20.

Early- and late-onset Alzheimer disease: Are they the same entity?

Tellechea P, Pujol N, Esteve-Belloch P, Echeveste B, García-Eulate MR, Arbizu J, Riverol M.

Neurologia (Engl Ed). 2018 May;33(4):244-253. doi: 10.1016/j.nrl.2015.08.002. Epub 2015 Nov 3.

Fornical Closed-Loop Stimulation for Alzheimer's Disease

Senova S, Chaillet A, Lozano AM.

Trends Neurosci. 2018 Jul;41(7):418-428. doi: 10.1016/j.tins.2018.03.015. Epub 2018 May 4.

Alzheimer's Disease and Parkinson's Disease: A Review of Current Treatment Adopting a Nanotechnology Approach

Trompetero A, Gordillo A, Del Pilar MC, Cristina VM, Bustos Cruz RH.

Curr Pharm Des. 2018;24(1):22-45. doi: 10.2174/1381612823666170828133059.

Common molecular pathogenesis of disease-related intrinsically disordered proteins revealed by NMR analysis

Shigemitsu Y, Hiroaki H.

J Biochem. 2018 Jan 1;163(1):11-18. doi: 10.1093/jb/mvx056.

A refined concept: α-synuclein dysregulation disease

Mochizuki H, Choong CJ, Masliah E.

Neurochem Int. 2018 Oct;119:84-96. doi: 10.1016/j.neuint.2017.12.011. Epub 2018 Jan 2.

Neuropathology correlates of cognitive assessments

Brett FM, Kearney H.

Ir J Med Sci. 2018 Aug;187(3):835-844. doi: 10.1007/s11845-017-1733-6. Epub 2018 Jan 18.

Mutation Screening of the CHCHD2 Gene for Alzheimer's Disease and Frontotemporal Dementia in Chinese Mainland Population

Che XQ, Zhao QH, Huang Y, Li X, Ren RJ, Chen SD, Guo QH, Wang G.

J Alzheimers Dis. 2018;61(4):1283-1288. doi: 10.3233/JAD-170692.

Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer's and Parkinson's disease models

Hölscher C.

Neuropharmacology. 2018 Jul 1;136(Pt B):251-259. doi: 10.1016/j.neuropharm.2018.01.040. Epub 2018 Jan 31.

Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study

Ballard C, Banister C, Khan Z, Cummings J, Demos G, Coate B, Youakim JM, Owen R, Stankovic S; ADP Investigators.

Lancet Neurol. 2018 Mar;17(3):213-222. doi: 10.1016/S1474-4422(18)30039-5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias